Mark J. Rubash Sells 1,709 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) Director Mark J. Rubash sold 1,709 shares of the business's stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $380.00, for a total transaction of $649,420.00. Following the completion of the transaction, the director now owns 16,051 shares in the company, valued at $6,099,380. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Intuitive Surgical Stock Up 0.4 %

Intuitive Surgical stock traded up $1.69 during mid-day trading on Monday, hitting $383.05. 878,161 shares of the stock were exchanged, compared to its average volume of 1,616,046. The firm's fifty day simple moving average is $385.40 and its two-hundred day simple moving average is $350.34. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76. The stock has a market capitalization of $135.87 billion, a price-to-earnings ratio of 68.84, a PEG ratio of 4.93 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm's revenue was up 11.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 EPS. As a group, analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Mizuho lifted their price target on Intuitive Surgical from $350.00 to $390.00 and gave the company a "neutral" rating in a report on Thursday, January 25th. Stifel Nicolaus raised their price target on Intuitive Surgical from $420.00 to $430.00 and gave the stock a "buy" rating in a research report on Monday, April 8th. Barclays upped their target price on Intuitive Surgical from $385.00 to $430.00 and gave the stock an "overweight" rating in a report on Thursday, January 25th. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an "overweight" rating in a report on Friday, January 19th. Finally, Citigroup increased their price target on Intuitive Surgical from $428.00 to $462.00 and gave the company a "buy" rating in a research note on Wednesday, April 3rd. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $396.17.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in ISRG. OFI Invest Asset Management bought a new stake in Intuitive Surgical during the 3rd quarter valued at $25,000. Baystate Wealth Management LLC lifted its holdings in Intuitive Surgical by 150.0% during the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 45 shares in the last quarter. MCF Advisors LLC grew its holdings in Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider's stock valued at $26,000 after buying an additional 40 shares in the last quarter. Headinvest LLC purchased a new stake in shares of Intuitive Surgical in the third quarter worth about $28,000. Finally, Able Wealth Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.